Quality of life in end-stage renal disease patients

被引:362
作者
Valderrábano, F [1 ]
Jofre, R [1 ]
López-Gómez, JM [1 ]
机构
[1] Univ Madrid, Hosp Gen Gregorio Maranon, Dept Nephrol, E-28007 Madrid, Spain
关键词
quality of life (QOL); end-stage renal disease (ESRD); chronic renal failure; predialysis; dialysis; kidney transplantation;
D O I
10.1053/ajkd.2001.26824
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Health-related quality of life (QOL) refers to the measure of a patient's functioning, well-being, and general health perception in each of three domains: physical, psychological, and social. Along with survival and other types of clinical outcomes, patient QOL is an important indicator of the effectiveness of the medical care they receive. QOL of patients with end-stage renal disease is influenced by the disease itself and by the type of replacement therapy. Numerous studies have identified the effect of such factors as anemia, age, comorbidity, and depression on QOL. Most of these factors appear during the predialysis period, and the adequate management of some of them could influence patient outcomes. Among replacement therapies, transplantation appears to give the best QOL for large groups of patients. No conclusive data exist to prove differences in QOL between hemodialysis patients and peritoneal dialysis patients. In the case of elderly patients or those with a high degree of comorbidity, the best treatment option should be assessed in each individual case, taking all possible factors into account. Finally, it has been proven that physical and mental function are inversely correlated with the risk for hospitalization and mortality. (C) 2001 by the National Kidney Foundation, Inc.
引用
收藏
页码:443 / 464
页数:22
相关论文
共 162 条
  • [1] Review of the concept of Quality of Life assessment and discussion of the present trend in clinical research
    Apolone, G
    Mosconi, P
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 : 65 - 69
  • [2] Arora P, 1999, J AM SOC NEPHROL, V10, P1281
  • [3] HEMODIALYSIS AND THE ELDERLY PATIENT - POTENTIAL ADVANTAGES AS TO QUALITY-OF-LIFE, UREA GENERATION, SERUM CREATININE, AND LESS INTERDIALYTIC WEIGHT-GAIN
    AVRAM, MR
    PENA, C
    BURRELL, D
    ANTIGNANI, A
    AVRAM, MM
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1990, 16 (04) : 342 - 345
  • [4] BADIA X, 1994, MED CLIN-BARCELONA, V102, P90
  • [5] CLINICAL AND PSYCHOLOGICAL CORRELATES OF SOMATIC SYMPTOMS IN PATIENTS ON DIALYSIS
    BARRETT, BJ
    VAVASOUR, HM
    MAJOR, A
    PARFREY, PS
    [J]. NEPHRON, 1990, 55 (01): : 10 - 15
  • [6] THE SICKNESS IMPACT PROFILE - DEVELOPMENT AND FINAL REVISION OF A HEALTH-STATUS MEASURE
    BERGNER, M
    BOBBITT, RA
    CARTER, WB
    GILSON, BS
    [J]. MEDICAL CARE, 1981, 19 (08) : 787 - 805
  • [7] SICKNESS IMPACT PROFILE - CONCEPTUAL FORMULATION AND METHODOLOGY FOR DEVELOPMENT OF A HEALTH STATUS MEASURE
    BERGNER, M
    BOBBITT, RA
    KRESSEL, S
    POLLARD, WE
    GILSON, BS
    MORRIS, JR
    [J]. INTERNATIONAL JOURNAL OF HEALTH SERVICES, 1976, 6 (03): : 393 - 415
  • [8] The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin
    Besarab, A
    Bolton, WK
    Browne, JK
    Egrie, JC
    Nissenson, AR
    Okamoto, DM
    Schwab, SJ
    Goodkin, DA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) : 584 - 590
  • [9] Beusterien KM, 1996, J AM SOC NEPHROL, V7, P763
  • [10] Bia M J, 1999, Geriatr Nephrol Urol, V9, P109, DOI 10.1023/A:1008387727084